Isabel Vogler

9PUBLICATIONS
46CO-AUTHORS
Innate immunitySolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 22, 2026
Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.

|Feb 18, 2026
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC.

U Sahin, M Schmidt, E Derhovanessian

|Jul 16, 2025
Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Uğur Şahin, Alexander Muik, Isabel Vogler

|Dec 10, 2023
The activating receptor NKp65 is selectively expressed by human ILC3 and demarcates ILC3 from mature NK cells.

Ines Kühnel, Isabel Vogler, Jessica Spreu

|Jun 02, 2022
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes.

Jasmin Quandt, Alexander Muik, Nadine Salisch

|Apr 05, 2022
Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens.

David Weber, Jonas Ibn-Salem, Patrick Sorn

Pageof 2

Frequent Collaborators

7 joint publications

Ugur Sahin

6 joint publications

Jasmin Quandt

5 joint publications

Alexander Muik

4 joint publications

Mathias Vormehr